Moderna files for European authorization of updated COVID vaccine
July 3 (Reuters) – U.S. biotech firm Moderna said on Monday it had submitted a regulatory application to the European Medicines Agency (EMA) seeking authorization for its updated COVID-19 vaccine to target the XBB.1.5 sub-variant.

Filed under
Business
Topics
Moderna


